Harvest Fund Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7
Closed -$2K 887
2022
Q3
$2K Hold
7
﹤0.01% 772
2022
Q2
$2K Hold
7
﹤0.01% 695
2022
Q1
$2K Hold
7
﹤0.01% 719
2021
Q4
$2K Hold
7
﹤0.01% 755
2021
Q3
$2K Sell
7
-6
-46% -$2.03K ﹤0.01% 747
2021
Q2
$4K Sell
13
-77
-86% -$23.6K ﹤0.01% 752
2021
Q1
$28K Buy
+90
New +$28.8K ﹤0.01% 596
2018
Q4
Sell
-524
Closed -$236K 481
2018
Q3
$236K Buy
524
+84
+19% +$33.1K 0.04% 130
2018
Q2
$180K Buy
440
+66
+18% +$23.9K 0.03% 83
2018
Q1
$108K Buy
+374
New +$94.8K 0.02% 113

Other funds holding ABMD

Harvest Fund Management's ABMD Position: Q4 2022 in Review

Harvest Fund Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 7 shares — an estimated $2K sold.

Harvest Fund Management first reported a position in ABMD in Q1 2018 and held it in 10 quarters. The position peaked at $236K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Harvest Fund Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Harvest Fund Management sold 7 Abiomed Inc shares in Q4 2022, an estimated $2K.
  • Harvest Fund Management first reported a position in Abiomed Inc in Q1 2018 and held it in 10 quarters.
  • Harvest Fund Management's Abiomed Inc position peaked at $236K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Harvest Fund Management's 13F filing for Q4 2022, filed 6 Feb 2023.